NATERA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
NATERA, INC. (NTRA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of -$133.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-27
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was -$133.41M.
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was -$62.97M.
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was -$6.42M, a 262.62% decline from fiscal 2022.
- NATERA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $3.95M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | -$133.41M 10-K · filed 2026-02-27 |
| 2024-12-31 | -$62.97M 10-K · filed 2026-02-27 |
| 2023-12-31 | -$6.42M 10-K · filed 2026-02-27 |
| 2022-12-31 | $3.95M 10-K · filed 2025-02-28 |
| 2021-12-31 | -$46.13M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$23.79M 10-K · filed 2023-03-01 |
| 2019-12-31 | -$7.54M 10-K · filed 2022-02-25 |
| 2018-12-31 | -$3.15M 10-K · filed 2021-02-26 |
| 2017-12-31 | -$5.04M 10-K · filed 2020-03-02 |
| 2016-12-31 | $1.27M 10-K · filed 2019-03-15 |
| 2015-12-31 | $1.68M 10-K · filed 2018-03-15 |
| 2014-12-31 | $755.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |